J.B. Chemicals & Pharmaceuticals has appointed Kaushal Solanki as its new Chief Financial Officer, effective February 5, 2026. The board also approved an interim dividend of ₹12.70 per equity share (1270% on face value of ₹1) for the financial year 2025-26. The dividend will be credited to shareholders on or after February 25, 2026.
New CFO Appointed
Kaushal Solanki has been appointed as the Chief Financial Officer (CFO) of J.B. Chemicals & Pharmaceuticals, effective February 5, 2026. He will also serve as Key Managerial Personnel within the company.
About Kaushal Solanki
Kaushal Solanki is a Chartered Accountant with over 30 years of experience in finance. Prior to joining J.B. Chemicals, he was associated with Torrent Pharmaceuticals Limited since October 2003, where he held several senior leadership roles.
Interim Dividend Declared
The board has declared an interim dividend of ₹12.70 per equity share of face value of ₹1 (1270%) for the financial year 2025-26. The dividend will be credited to the shareholders on or after February 25, 2026.
Source: BSE
